HUMANETICS CORP
BIO 300, a nanosuspension of synthetic genistein, a small-molecule therapeutic for idiopathic pulmonary fibrosis
- Sector
- Biotech
- Headquarters
- Edina, MN
- Total capital
- $23.8M
- Federal grants
- $1.8M
- 5 awards · 2016–2023
- Rank in peer group#17 of 502
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $22M
- 5 awards · Defense, Health and Human S, NASA
- Rank in Biotech#39 of 4373
- Granted patents
- None on recordNo USPTO grants. Applications publish after 18 months.
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase I · Development of BIO 300 as a novel treatment for idiopathic pulmonary fibrosis$298K
- Federal grantHealth and Human S · Phase I · Development of BIO 300 as a novel treatment for idiopathic pulmonary fibrosis$298K
- Federal contractHealth and Human S · Igf::ot::igf An Nhp Efficacy Study Of Bio 300 For Mitigator For Deare-induced Pneumonitis And Pulmonary Fibrosis$10.3M
- Federal grantHealth and Human S · Phase I · Development of BIO 300 as a MCM for lethal radiation pneumonitis/fibrosis$298K
- Federal contractNASA · Igf::ot::igf The Cumulative Dose Of Radiation Exposure To Our Astronauts Remains One Of The Limiting Roadblocks To Longer Duration Missions In Space. Humanetics Corporation (humanetics) Is Developing A Novel Radioprotectant, Bio 300, For Use In Both Clinical Radiotherapy And As A Radiation Countermeasure. Bio 300 Is A Safe, Shelf-stable Pharmaceutical Which Has Been Shown To Mitigate Both The Acute And Delayed Effects Of Radiation Exposure. Bio 300 Is In Advanced Stages Of Clinical Development,$125K
- Federal grantHealth and Human S · Phase I · Development of BIO as a MCM for lethal radiation pneumonitis fibrosis$597K
- Federal grantHealth and Human S · Phase I · Development of BIO 300 as a MCM for lethal radiation pneumonitis/fibrosis$299K
Show 3 earlier federal awards
- Federal contractHealth and Human S · Igf::ot::igf Other Functions R&d- Medical: Biomedical (basic Research)$1.7M
- Federal contractHealth and Human S · Humanetics Corporation Base Year Contract Can 1992002$3.5M
- Federal contractDefense · Pharmacological Countermeasures To$6.3M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 502 peers
Line = medianBiotech · Molecule
- Federal grants#17 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
No granted patents are on record.
USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.
Checked: USPTO granted patents and published applications · Oct 23, 2026
Related companies, and why
- PARABON NANOLABS, INC.Similar federal contract value in Biotech · $24.7M in contracts
- MICROBIOTIX, INC.Similar federal contract value in Biotech · $23.7M in contracts
- Biospyder Technologies, Inc.Similar federal contract value in Biotech · $23.1M in contracts
- Chrysalis BioTherapeutics, Inc.Similar federal contract value in Biotech · $21.7M in contracts
- Mammoth BiosciencesSimilar federal contract value in Biotech · $20.8M in contracts
- Oxford Nanopore TechnologiesSimilar federal contract value in Biotech · $19.9M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .